Russia’s Supreme Court has rejected an appeal by the American company Gilead Sciences, which challenges the decision made by the Russian government last year for the well-known drug against Covid-19, remdesivir.
The decision of the Russian government allowed a Russian pharmaceutical company to develop the drug remdesivir (Remdesivir) against Covid-19, without the consent of Gilead Sciences.
The Russian company Pharmasyntez today sent the generic version of the drug remdesivir, which is called Remdeform, to India as part of its humanitarian aid, as broadcast by Reuters and rebroadcast by the Athens News Agency.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
